InvestorsHub Logo
Followers 30
Posts 1475
Boards Moderated 0
Alias Born 07/10/2013

Re: None

Thursday, 09/09/2021 8:08:12 PM

Thursday, September 09, 2021 8:08:12 PM

Post# of 44690
Gain of function research includes any research that makes viruses more transmissible and more deadly. According to the document obtained by The Intercept the NIH was specifically funding GOF to spike the gene of one coronavir...

https://trialsitenews.com/the-intercept-document-dump-reveals-troubling-evidence-of-gof-research-did-dr-anthony-fauci-lie-to-congress/

DRUG LOBBY ASKS BIDEN TO PUNISH FOREIGN COUNTRIES PUSHING FOR LOW-COST VACCINES ———
Big Pharma is fighting for tight control over Covid-19 vaccine production, limiting availability worldwide while reaping billions.

https://theintercept.com/2021/03/03/vaccine-coronavirus-big-pharma-biden/

What if all of the assumptions that people are making about this COVID pandemic are completely wrong?  When Pfizer announced that they had developed a successful vaccine for COVID, the world cheered.  And then when Moderna announced that they had developed a successful vaccine for COVID, the world cheered even more.  But COVID has been mutating, and scientists assure us that it will keep mutating.  So what happens if the vaccines that are being developed end up being completely useless against new mutant strains of the virus?  Would that put us all the way back to square one (or even worse)?

https://www.zerohedge.com/medical/new-strains-covid-could-render-vaccines-completely-useless-and-2-dangerous-mutations-are

WHAT SIDE EFFECTS???

https://medicalkidnap.com/2021/08/18/censored-covid-vaccine-injured-who-regret-their-decisions-to-get-the-shot-and-their-message-to-you/

Dr Malone asks why health leaders seem to be so afraid of sharing the adverse event data. He says, "Why is it necessary to suppress discussion and full disclosure of information concerning mRNA reactogenicity and safety risks?"
He goes onto say that we should be analysing the safety data and risks vigorously. Again he asks, "Is there information or patterns that can be found, such as the recent finding of the cardiomyopathy signals, or the latent virus reactivation signals?  We should be enlisting the best biostatistics and machine learning experts to examine these data, and the results should- no must- be made available to the public promptly". ————
For any drug it has always been important to have systems in place for monitoring adverse events. However, for an experimental, genetic modifying approach that has not been fully tested, and where the public are effectively the guinea pigs, this information should be immediately and readily available. As previously reported in Total Health, the fact that it is so difficult to access and make sense of the US VAERS, and UK Yellow Card reporting systems - along with low reporting simply raises further concern about what is actually happening.

https://www.totalhealth.co.uk/blog/are-people-getting-full-facts-covid-vaccine-risks

VITAL ORGANS??? ———

These are the brain, heart, kidneys, liver and lungs. The human brain is the body's control center, receiving and sending signals to other organs through the nervous system and through secreted hormones.

https://www.livescience.com/37009-human-body.html

DOES VIP HAVE YOU COVERED???

Using Northern blotting, VPAC1 is localized to lung > prostate > peripheral leukocyte, liver, brain, small intestine > colon, heart, spleen > placenta, kidney, thymus, testis (decreasing order of expression). By receptor autoradiography, VPAC1 is expressed in many epithelial cells, such as hepatocytes, mucosal cells of the stomach and colon, acinar and/or duct cells of the breast, pancreas, and lung, and glandular cells of the thyroid, prostate, uterus, and adrenal medulla.

https://www.sciencedirect.com/topics/neuroscience/vasoactive-intestinal-polypeptide-receptor-1

CAN THE BEST OF VACCINES DO THIS???

Because of its lack of toxicity and low cost of manufacture compared to proprietary biologics, VIP may be uniquely attractive to those focused on global countermeasures against COVID-19, says the company.
VIP is known to target the VPAC1 receptor of the alveolar type II cell (ATII) cell and protect that cell against all manner of injuries, including smoke inhalation, exposure to stomach acid, and exposure to infectious agents. In addition, VIP prevents apoptosis, blocks cytokines, lowers TNFa levels, reverses CD4/CD8 ratio, and reduces cough and dyspnea in nonclinical and clinical studies.

https://www.precisionvaccinations.com/vaccines/zyesami-aviptadil-covid-19-therapeutic